ery-ped

Generic: erythromycin ethylsuccinate

Labeler: azurity pharmaceuticals, inc. (formerly arbor pharmaceuticals)
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name ery-ped
Generic Name erythromycin ethylsuccinate
Labeler azurity pharmaceuticals, inc. (formerly arbor pharmaceuticals)
Dosage Form SUSPENSION
Routes
ORAL
Active Ingredients

erythromycin ethylsuccinate 400 mg/5mL

Manufacturer
Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)

Identifiers & Regulatory

Product NDC 24338-130
Product ID 24338-130_0ca6c02b-5b9f-39c3-e063-6294a90a4c18
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA050207
Listing Expiration 2026-12-31
Marketing Start 2012-06-14

Pharmacologic Class

Classes
decreased sebaceous gland activity [pe] macrolide antimicrobial [epc] macrolide [epc] macrolides [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 24338130
Hyphenated Format 24338-130

Supplemental Identifiers

RxCUI
686400 686402 686418 686420
UNII
1014KSJ86F

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name ery-ped (source: ndc)
Generic Name erythromycin ethylsuccinate (source: ndc)
Application Number NDA050207 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 400 mg/5mL
source: ndc
Packaging
  • 100 mL in 1 BOTTLE (24338-130-13)
source: ndc

Packages (1)

Ingredients (1)

erythromycin ethylsuccinate (400 mg/5mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "0ca6c02b-5b9f-39c3-e063-6294a90a4c18", "openfda": {"unii": ["1014KSJ86F"], "rxcui": ["686400", "686402", "686418", "686420"], "spl_set_id": ["04775721-ab87-4b66-808c-d67a21032385"], "manufacturer_name": ["Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 mL in 1 BOTTLE (24338-130-13)", "package_ndc": "24338-130-13", "marketing_start_date": "20120614"}], "brand_name": "Ery-Ped", "product_id": "24338-130_0ca6c02b-5b9f-39c3-e063-6294a90a4c18", "dosage_form": "SUSPENSION", "pharm_class": ["Decreased Sebaceous Gland Activity [PE]", "Macrolide Antimicrobial [EPC]", "Macrolide [EPC]", "Macrolides [CS]"], "product_ndc": "24338-130", "generic_name": "Erythromycin Ethylsuccinate", "labeler_name": "Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ery-Ped", "active_ingredients": [{"name": "ERYTHROMYCIN ETHYLSUCCINATE", "strength": "400 mg/5mL"}], "application_number": "NDA050207", "marketing_category": "NDA", "marketing_start_date": "20120614", "listing_expiration_date": "20261231"}